AIM ImmunoTech
12 hedge funds and large institutions have $192K invested in AIM ImmunoTech in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.
8% less funds holding
Funds holding: 13 → 12 (-1)
23% less capital invested
Capital invested by funds: $248K → $192K (-$56K)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$22.3K |
| 2 |
VF
Virtu Financial
New York
|
+$13.4K |
| 3 |
AG
Advisor Group
Phoenix,
Arizona
|
+$890 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$26K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$16.9K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$9K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$4.45K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
BlackRock
New York
| $74K | – | – | – |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $58K | -$16.9K | -19 | -19% |
|
|
3
UBS Group
Zurich,
Switzerland
| $26K | +$22.3K | +25 | +208% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $11K | – | – | – |
|
|
VF
5
Virtu Financial
New York
| $11K | +$13.4K | +15 | New |
|
6
Northern Trust
Chicago,
Illinois
| $5K | – | – | – |
|
|
OAM
7
Occidental Asset Management
Burlingame,
California
| $3K | – | – | – |
|
|
TSS
8
Two Sigma Securities
New York
| $2K | -$4.45K | -5 | -71% |
|
|
WPW
9
Waldron Private Wealth
Bridgeville,
Pennsylvania
| $1K | – | – | – |
|
|
RIA
10
Realta Investment Advisors
Wilmington,
Delaware
| $1K | +$890 | +1 | New |
|
|
11
Citadel Advisors
Miami,
Florida
| – | -$26K | -32 | Closed |
|
|
12
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$11K | -14 | Closed |
|
|
PP
13
Paloma Partners
Greenwich,
Connecticut
| – | -$9K | -11 | Closed |
|
14
Invesco
Atlanta,
Georgia
| – | -$2K | -3 | Closed |
|
|
AG
15
Advisor Group
Phoenix,
Arizona
| – | +$890 | +1 | New |
|
AIM Hedge Fund Activity: Q1 2019 in Review
12 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q1 2019, worth a combined $192K — down 23% from $248K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of AIM and 3 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $22.3K. The largest seller was Citadel Advisors, exiting entirely with an estimated $26K sold.
- 12 institutional investors held AIM ImmunoTech (AIM) as of Q1 2019, down from 13 in Q4 2018.
- Funds reported $192K of AIM ImmunoTech stock for Q1 2019, down 23% quarter-over-quarter.
- 3 funds opened new AIM ImmunoTech positions in Q1 2019 and 4 closed out, a net change of -1 holder.
- The largest AIM ImmunoTech buyer in Q1 2019 was UBS Group, an estimated $22.3K added.
- The largest AIM ImmunoTech seller in Q1 2019 was Citadel Advisors, an estimated $26K sold.
Based on aggregated 13F filings for Q1 2019.